coronavirus
Professor Heidi Larson: “This is a key moment to build trust in countries and socio-economic groups with relatively low confidence in vaccines.”
For over a decade, Heidi Larson, Professor of Anthropology, Risk and Decision Science at the London School of Hygiene & Tropical Medicine, has been leading global efforts to monitor public confidence in immunisation programmes. As COVID-19 vaccination programmes are rolled out across the EU, this is a key moment to build trust in countries and ...
Joana Gonçalves de Sá: “Mitigate the misinformation pandemic by ‘vaccinating’ the susceptible individuals first.”
Joana Gonçalves de Sá is an Invited Associate Professor at the Physics Department of Instituto Superior Técnico, Universidade de Lisboa, and was the recipient of an ERC Starting Grant to study human behaviour using the online spread of ’fake news’ as a model system. Disinformation and misinformation are not a new problem, so why did ...
ESMH Media Review – March 10, 2021
Covid-19 vaccine, climate change & DSA: check out the ESMH selection of 27 science and tech news published in the last weeks on the web.
A scientist’s opinion : Interview with Prof. András Falus about SARS-CoV-2 mutations
András Falus was born in 1947 in Budapest, Hungary and is a professor emeritus of Budapest’s Semmelweis University and a member of the Hungarian Academy of Sciences. His primary field of study is immunogenomics, allergy and onco-genomics. Most recently, his research has focused on histamine-related immunoregulation, non-coding DNA (e.g. microRNA) and microvesicles, a newly recognised ...
A scientist’s opinion: Interview with Dr Deepti Gurdasani about SARS-CoV-2 mutations
Dr Deepti Gurdasani ’s background is as a clinical epidemiologist and statistical geneticist. After completing her clinical training in internal medicine at Christian Medical College, Vellore, India, she completed her MPhil in epidemiology and biostatistics at the University of Cambridge in 2010, followed by a PhD examining genetic factors associated with disease in genetically diverse ...
SARS-CoV-2: the challenges of mutation and possible strategies
The efficacy of the current COVID-19 vaccines might be lower against the new variants of SARS-CoV-2. The new strain that emerged in the United Kingdom has a higher transmissibility than previous strains of the virus. We asked scientists whether the new mutations are a threat to the current public health measures and to COVID-19 vaccines.
Covid-19: different types of vaccines and how they work
A range of Covid-19 vaccines are being developed worldwide and the differences between them can be confusing. How do the new mRNA vaccines work? What about vector vaccines? We asked scientists to give us an insight into the different types of Covid-19 vaccines.
ESMH Media Review – February 17, 2021
Coronavirus, autonomous cars & media literacy. Check out the ESMH selection of 30 science and tech news published in the last weeks on the web.
